Integra LifeSciences Holdings (IART) is a publicly traded Healthcare sector company. As of May 21, 2026, IART trades at $15.40 with a market cap of $1.10B and a P/E ratio of -2.33. IART moved +7.06% today. Year to date, IART is +22.53%; over the trailing twelve months it is +15.54%. Its 52-week range spans $8.70 to $27.13. Analyst consensus is neutral with an average price target of $15.60. Rallies surfaces IART's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Which politicians traded IART stock?
Recent politician trading activity in IART includes disclosures from Josh Gottheimer and Josh Gottheimer. Rallies tracks purchase and sale disclosures, transaction dates, owners, reported amounts, and post-trade performance context.
IART Key Metrics
Key financial metrics for IART
Metric
Value
Price
$15.40
Market Cap
$1.10B
P/E Ratio
-2.33
EPS
$-6.46
Dividend Yield
0.00%
52-Week High
$27.13
52-Week Low
$8.70
Volume
112
Avg Volume
0
Revenue (TTM)
$1.64B
Net Income
$-495.80M
Gross Margin
51.94%
Congressional Trades in IART
Josh Gottheimer sale IART on Jun 18, 2024 (amount: $15.00K) for Joint.
Josh Gottheimer sale (partial) IART on Apr 5, 2024 (amount: $15.00K) for Joint.
Recent politician trading activity in IART includes disclosures from Josh Gottheimer and Josh Gottheimer. Rallies tracks purchase and sale disclosures, transaction dates, owners, reported amounts, and post-trade performance context.
Does Rallies track congressional trades in IART?
Yes. Rallies tracks politician and congressional stock disclosures for IART, including reported purchases, sales, dates, owners, and trade amounts when available.
Is IART research on Rallies investment advice?
No. Rallies provides research, data, and educational context for IART. It does not provide personalized investment advice.
